# Primary Mediastinal Large B-cell Lymphoma (PMBCL): Multicenter Retrospective Study

> **NCT05162170** · — · COMPLETED · sponsor: **Fondazione Italiana Linfomi - ETS** · enrollment: 633 (actual)

## Conditions studied

- Primary Mediastinal Large B-cell Lymphoma (PMBCL)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05162170
- **Lead sponsor:** Fondazione Italiana Linfomi - ETS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-02
- **Primary completion:** 2022-12-05
- **Final completion:** 2025-07-11
- **Target enrollment:** 633 (ACTUAL)
- **Last updated:** 2025-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05162170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05162170, "Primary Mediastinal Large B-cell Lymphoma (PMBCL): Multicenter Retrospective Study". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05162170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*